ScholarLens Back to search
2014•Acta Scientiarum Naturalium Universitatis SunyatseniRequires access

Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

Dejian, Pan Pan, Biao, Wang, Weibing, Yuanwen, Wu, Xijian, Zhou, Donglin

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Gefitinib, Medicine, Oncology, Adenocarcinoma of the lung, Adenocarcinoma, Regimen, Lung cancer, Internal medicine

Back to paper searchBrowse research topicsOriginal source
Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen — Research Paper | ScholarLens